ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Women's Health Study: Biomarkers"
Episode Synopsis
Paul Ridker and C. Michael Gibson discuss 30-year data hinting at how three modifiable factors—LDL, hs-CRP, and Lp(a)—might be leveraged to reduce long-term risk. 06f763f0-76e5-11f0-bb7c-8557ae1d8a8b
More episodes of the podcast Talking Points
The ECLIPSE Trial
01/10/2025
The CLEAR SYNERGY (OASIS 9) Trial
17/09/2025
The NOTION-3 Trial
03/09/2025
TMVR in the Heart Failure Paradigm
15/08/2025
The ABYSS Trial
13/08/2025
Patient Selection and Treatment Goals
11/08/2025
Echocardiography and Quality Data
04/08/2025
Insights on Intrepid 2-Yr Mitral TF EFS
30/07/2025
New ESC Guidelines for AF
23/07/2025
The STEEER-AF Trial
09/07/2025
In God we trust